RENO, Nevada, Jan. 16, 2019 (GLOBE NEWSWIRE) -- Earth Life Sciences Inc., (the company) (OTC "CLTS") is pleased to announce following several meetings with owners of Prime bottom land, the company has agreed to lease land and joint venture the building of capital improvements for the propagation of cloned Hemp plants to be raised for fiber, food and CBD oil contained within. Hemp is not Pot. It is a Miraculous plant with life giving health benefits usable in over 25,000 clean, green industrial products. Hemp cloned and cultivated can be a very lucrative crop. Expert farmers with modern sophisticated equipment can raise hemp with 10 percent CBD content with an estimated market value of $25 to $35 per pound with a yield of one pound per plant and up to 2,500 plants per acre. That's around $60,000 per acre. The company plans to joint venture with several native families and manage approximately 6,000 acres of Hemp by 2022. Estimated gross income could exceed $300 million.

Earth Life Sciences: “Growing for the good of our shareholders.”

EARTH LIFE SCIENCES INC.

ANGELO MARINO
CEO
info@earthlifesciences.com

Forward Looking Information

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain, and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control including, the Company's ability to compete with large food companies; sales of any potential products developed will be profitable; the ability to complete sales under the sales agreement.  Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.